Skip to main content
Top
Published in: Diabetes Therapy 3/2017

Open Access 01-06-2017 | Commentary

Comment on the New Indian Injection Technique Recommendations: Critical Appraisal of the Real-World Implementation of the Current Guidelines

Authors: Felice Strollo, Sandro Gentile

Published in: Diabetes Therapy | Issue 3/2017

Login to get access

Abstract

With an eye on the sequence of two Indian papers concurrently published in Diabetes Therapy, this paper analyzes skin differences among races and points to a lack of organized structured education sessions as the main cause of the high prevalence of lipodystrophy (LD) and consequent poor metabolic control. Only half of all insulin-treated patients reach their therapeutic targets worldwide. The factors involved in this are manifold, including the choice of overlong and repeatedly reused needles, as well as a failure to systematically rotate injection sites, all of which lead to skin LD. Regularly issued guidelines and expert recommendations provide suggestions about how to correct poor injection techniques, but LD still occurs at a high rate and is associated with poor metabolic control, a high risk of complications, frequent severe hypoglycemic episodes, and huge health and social costs. Poor knowledge of subcutaneous tissue anatomy and the physiological response to insulin injection by both health care personnel and patients may contribute to this problem. Moreover, differences in body structure among the races present in our multiethnic societies must be taken into account when choosing needle length and shooting technique in order to avoid accidental intramuscular injections.
Literature
1.
go back to reference Indian Injection Technique Study. Population characteristics and injection practices. Diabetes Ther. 2017 (in press). Indian Injection Technique Study. Population characteristics and injection practices. Diabetes Ther. 2017 (in press).
2.
go back to reference Indian Injection Technique Study. Injecting complications, education and the health care professional. Diabetes Ther. 2017 (in press). Indian Injection Technique Study. Injecting complications, education and the health care professional. Diabetes Ther. 2017 (in press).
3.
go back to reference De Cosmo S, Viazzi F, Pacilli A, Giorda C, Ceriello A, Gentile S, Russo G, Rossi MC, Nicolucci A, Guida P, Di Bartolo P, Pontremoli R, the AMD Annals Study Group. Achievement of therapeutic targets in patients with diabetes and chronic kidney disease: insights from the Associazione Medici Diabetologi Annals initiative. Nephrol Dial Transplant. 2015;30(9):1526–33. De Cosmo S, Viazzi F, Pacilli A, Giorda C, Ceriello A, Gentile S, Russo G, Rossi MC, Nicolucci A, Guida P, Di Bartolo P, Pontremoli R, the AMD Annals Study Group. Achievement of therapeutic targets in patients with diabetes and chronic kidney disease: insights from the Associazione Medici Diabetologi Annals initiative. Nephrol Dial Transplant. 2015;30(9):1526–33.
5.
go back to reference Hofman PL, Derraik JG, Pinto TE, Tregurtha S, Faherty A, Peart JM, Drury PL, Robinson E, Tehranchi R, Donsmark M, Cutfield WS. Defining the ideal injection techniques when using 5-mm needles in children and adults. Diabetes Care. 2010;33:1940–4. doi:10.2337/dc10-0871 (Epub 2010 Jun 28).CrossRefPubMedPubMedCentral Hofman PL, Derraik JG, Pinto TE, Tregurtha S, Faherty A, Peart JM, Drury PL, Robinson E, Tehranchi R, Donsmark M, Cutfield WS. Defining the ideal injection techniques when using 5-mm needles in children and adults. Diabetes Care. 2010;33:1940–4. doi:10.​2337/​dc10-0871 (Epub 2010 Jun 28).CrossRefPubMedPubMedCentral
6.
go back to reference Spollett G, Edelman SV, Mehner P, Walter C, Penfornis A. Improvement of insulin injection technique: examination of current issues and recommendations. Diabetes Edu. 2016;42(4):379–94. doi:10.1177/0145721716648017 (Epub 2016 May 23).CrossRef Spollett G, Edelman SV, Mehner P, Walter C, Penfornis A. Improvement of insulin injection technique: examination of current issues and recommendations. Diabetes Edu. 2016;42(4):379–94. doi:10.​1177/​0145721716648017​ (Epub 2016 May 23).CrossRef
8.
go back to reference Gentile S, Agrusta M, Guarino G, Carbone L, Cavallaro V, et al. Metabolic consequence of incorrect insulin administration techniques in aging subjects with diabetes. Acta Diabetol. 2011;48:121–5.CrossRefPubMed Gentile S, Agrusta M, Guarino G, Carbone L, Cavallaro V, et al. Metabolic consequence of incorrect insulin administration techniques in aging subjects with diabetes. Acta Diabetol. 2011;48:121–5.CrossRefPubMed
9.
go back to reference Giorda CB, Ozzello A, Gentile S, Aglialoro A, Chiambretti A, Baccetti F, Gentile FM, Lucisano G, Nicolucci A. Rossi MC; HYPOS-1 Study Group of AMD. Incidence and risk factors for severe and symptomatic hypoglycemia in type 1 diabetes. Results of the HYPOS-1 study. Acta Diabetol. 2015;52:845–53. doi:10.1007/s00592-015-0713-4 (Epub 2015 Feb 12).CrossRefPubMed Giorda CB, Ozzello A, Gentile S, Aglialoro A, Chiambretti A, Baccetti F, Gentile FM, Lucisano G, Nicolucci A. Rossi MC; HYPOS-1 Study Group of AMD. Incidence and risk factors for severe and symptomatic hypoglycemia in type 1 diabetes. Results of the HYPOS-1 study. Acta Diabetol. 2015;52:845–53. doi:10.​1007/​s00592-015-0713-4 (Epub 2015 Feb 12).CrossRefPubMed
10.
go back to reference Sim KH, Hwang MS, Kim SY, Lee HM, Chang JY, Lee MK. The appropriateness of the length of insulin needles based on determination of skin and subcutaneous fat thickness in the abdomen and upper arm in patients with type 2 diabetes. Diabetes Metab J. 2014;38:120–33. doi:10.4093/dmj.2014.38.2.120 (Epub 2014 Apr 18).CrossRefPubMedPubMedCentral Sim KH, Hwang MS, Kim SY, Lee HM, Chang JY, Lee MK. The appropriateness of the length of insulin needles based on determination of skin and subcutaneous fat thickness in the abdomen and upper arm in patients with type 2 diabetes. Diabetes Metab J. 2014;38:120–33. doi:10.​4093/​dmj.​2014.​38.​2.​120 (Epub 2014 Apr 18).CrossRefPubMedPubMedCentral
11.
go back to reference Wanga W, Guoa X, Shena G, Baib G, Weic Z, Liuc J, Hirschd L, Strauss K. Skin and subcutaneous tissue thickness at insulin injection sites in Chinese diabetes patients: clinical implications. Diabetes Metab. 2016;42:374–7.CrossRef Wanga W, Guoa X, Shena G, Baib G, Weic Z, Liuc J, Hirschd L, Strauss K. Skin and subcutaneous tissue thickness at insulin injection sites in Chinese diabetes patients: clinical implications. Diabetes Metab. 2016;42:374–7.CrossRef
12.
go back to reference Catambing, Villa M. Ultrasonographic measurement of skin and subcutaneous thickness at insulin injection sites among adult Filipinos with diabetes. JAFES. 2014;29:24–32.CrossRef Catambing, Villa M. Ultrasonographic measurement of skin and subcutaneous thickness at insulin injection sites among adult Filipinos with diabetes. JAFES. 2014;29:24–32.CrossRef
13.
go back to reference Joo G, Sohng KY. Gluteal subcutaneous fat thickness measured by computed tomography as an estimate of proper gluteal intramuscular injections in Korean adults. J Korean Acad Nurs. 2010;40:247–54.CrossRefPubMed Joo G, Sohng KY. Gluteal subcutaneous fat thickness measured by computed tomography as an estimate of proper gluteal intramuscular injections in Korean adults. J Korean Acad Nurs. 2010;40:247–54.CrossRefPubMed
14.
go back to reference Jain SM, Pandey K, Lahoti A, Rao PK. Evaluation of skin and subcutaneous tissue thickness at insulin injection sites in Indian, insulin naïve, type-2 diabetic adult population. Indian J Endocrinol Metab. 2013;17:864–70.CrossRefPubMedPubMedCentral Jain SM, Pandey K, Lahoti A, Rao PK. Evaluation of skin and subcutaneous tissue thickness at insulin injection sites in Indian, insulin naïve, type-2 diabetic adult population. Indian J Endocrinol Metab. 2013;17:864–70.CrossRefPubMedPubMedCentral
15.
go back to reference Gibney MA, Arce CH, Byron KJ, Hirsch L. Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations. Curr Med Res Opin. 2010;26:1519–30.CrossRefPubMed Gibney MA, Arce CH, Byron KJ, Hirsch L. Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations. Curr Med Res Opin. 2010;26:1519–30.CrossRefPubMed
16.
go back to reference LoPresti D, Ingegnosi C, Strauss K. Skin and subcutaneous thickness at injecting sites in children with diabetes: ultrasound findings and recommendations for giving injection. Pediatr Diabetes. 2012;13:525–33.CrossRef LoPresti D, Ingegnosi C, Strauss K. Skin and subcutaneous thickness at injecting sites in children with diabetes: ultrasound findings and recommendations for giving injection. Pediatr Diabetes. 2012;13:525–33.CrossRef
17.
go back to reference Gentile S, Strollo F, Guarino G, Giancaterini A, Ames PRJ, Speese K, Guida P, Strauss K, on behalf of the AMD-OSDI Italian Injection Technique Study Group. Factors hindering correct identification of unapparent lipohypertrophy. J Diabetes Metab Disord Control. 2016;3(2):00065. doi:10.15406/jdmdc.2016.03.00065. Gentile S, Strollo F, Guarino G, Giancaterini A, Ames PRJ, Speese K, Guida P, Strauss K, on behalf of the AMD-OSDI Italian Injection Technique Study Group. Factors hindering correct identification of unapparent lipohypertrophy. J Diabetes Metab Disord Control. 2016;3(2):00065. doi:10.​15406/​jdmdc.​2016.​03.​00065.
18.
go back to reference Strollo F, Guarino G, Armentano V, Clemente G, Martedì E, De Riu S, Gaeta I, Corigliano G, Ceriello A, Gentile S, on behalf of AMD-OSDI Italian Study Group on Injection Techniques. Unexplained hypoglycaemia and large glycaemic variability: skin lipohypertrophy as a predictive sign. Diabetes Res Open J. 2016. doi:10.17140/DROJ-2-126. Strollo F, Guarino G, Armentano V, Clemente G, Martedì E, De Riu S, Gaeta I, Corigliano G, Ceriello A, Gentile S, on behalf of AMD-OSDI Italian Study Group on Injection Techniques. Unexplained hypoglycaemia and large glycaemic variability: skin lipohypertrophy as a predictive sign. Diabetes Res Open J. 2016. doi:10.​17140/​DROJ-2-126.
19.
go back to reference Grassi G, Scuntero P, Trepiccioni R, Marubbi F, Strauss K. Optimizing insulin injection technique and its effect on blood glucose control. J Clin Transl Endocrinol. 2014;1:145–50.CrossRef Grassi G, Scuntero P, Trepiccioni R, Marubbi F, Strauss K. Optimizing insulin injection technique and its effect on blood glucose control. J Clin Transl Endocrinol. 2014;1:145–50.CrossRef
21.
22.
go back to reference Giorda CB, Rossi MC, Ozzello O, Gentile S, Aglialoro A, Chiambretti A, Baccetti F, Gentile FM, Romeo F, Lucisano G, Nicolucci A; HYPOS-1 Study Group of AMD. Healthcare resource use, direct and indirect costs of hypoglycemia in type 1 and type 2 diabetes, and nationwide projections: results of the HYPOS-1 study. Nutr Metab Cardiovasc Dis. 2017;27(3):209–216. Giorda CB, Rossi MC, Ozzello O, Gentile S, Aglialoro A, Chiambretti A, Baccetti F, Gentile FM, Romeo F, Lucisano G, Nicolucci A; HYPOS-1 Study Group of AMD. Healthcare resource use, direct and indirect costs of hypoglycemia in type 1 and type 2 diabetes, and nationwide projections: results of the HYPOS-1 study. Nutr Metab Cardiovasc Dis. 2017;27(3):209–216.
Metadata
Title
Comment on the New Indian Injection Technique Recommendations: Critical Appraisal of the Real-World Implementation of the Current Guidelines
Authors
Felice Strollo
Sandro Gentile
Publication date
01-06-2017
Publisher
Springer Healthcare
Published in
Diabetes Therapy / Issue 3/2017
Print ISSN: 1869-6953
Electronic ISSN: 1869-6961
DOI
https://doi.org/10.1007/s13300-017-0262-7

Other articles of this Issue 3/2017

Diabetes Therapy 3/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.